Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT05731050 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

PNH - Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: NM8074

Sponsor

NovelMed Therapeutics